Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Make your choice for the music application with the most amicable connection point! - 2Shrapnel hits across central Israel, injuring several, causing property damage
- 3Did we start the fire? A 400,000-year-old hearth sparks new questions about human evolution
- 4Yes, NASA's launching Artemis 2 astronauts to the moon on April Fools' Day. It's not a joke.
- 5Figure out How to Back Your Rooftop Substitution
- Figuring out the Justification for Separation: To blame and No-Shortcoming
- James Webb Space Telescope discovers a lemon-shaped exoplanet unlike anything seen before: 'What the heck is this?'
- Genetic study identifies earliest-known dog, dating to 15,800 years ago
- Ten Awesome Authentic Realities That Will Leave You Interested
- Instructions to Choose the Best Material Organization for a Fruitful Rooftop Substitution
- Geminid meteors streak under green sky | Space photo of the day for Dec. 19, 2025
- \Step by step instructions to Pick the Best Material Organization for Your Home\
- Investigating Design and Individual Style: Track down Your Remarkable Look
- First stop, the Moon. Next stop, Mars? Why Nasa's mission matters
